These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10408570)

  • 21. Serum insulin and leptin levels in valproate-associated obesity.
    Pylvänen V; Knip M; Pakarinen A; Kotila M; Turkka J; Isojärvi JI
    Epilepsia; 2002 May; 43(5):514-7. PubMed ID: 12027912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum insulin and leptin levels and valproate-associated obesity.
    Verrotti A; di Corcia G; Salladini C; Trotta D; Morgese G; Chiarelli F
    Epilepsia; 2003 Dec; 44(12):1606. PubMed ID: 14636339
    [No Abstract]   [Full Text] [Related]  

  • 23. Metabolic alterations during valproic acid treatment: a prospective study.
    Abaci A; Saygi M; Yis U; Demir K; Dirik E; Bober E
    Pediatr Neurol; 2009 Dec; 41(6):435-9. PubMed ID: 19931165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does long-term use of valproate cause weight gain in prepubertal epileptic children?
    Caksen H; Deda G; Berberoğlu M
    Int J Neurosci; 2002 Oct; 112(10):1183-9. PubMed ID: 12587521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of valproic acid-associated weight gain in prepubertal children.
    Espinosa PS; Salazar JC; Yu L; Mendiondo MS; Robertson WC; Baumann RJ
    Pediatr Neurol; 2008 Sep; 39(3):177-80. PubMed ID: 18725062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluate the effects of antiepileptic drugs on reproductive endocrine system in newly diagnosed female epileptic patients receiving either Valproate or Lamotrigine monotherapy: A prospective study.
    Sidhu HS; Srinivasa R; Sadhotra A
    Epilepsy Res; 2018 Jan; 139():20-27. PubMed ID: 29144993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of excessive weight gain in epileptic children treated with valproate.
    Novak GP; Maytal J; Alshansky A; Eviatar L; Sy-Kho R; Siddique Q
    J Child Neurol; 1999 Aug; 14(8):490-5. PubMed ID: 10456757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea.
    Laughlin GA; Dominguez CE; Yen SS
    J Clin Endocrinol Metab; 1998 Jan; 83(1):25-32. PubMed ID: 9435412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Body weight gain after administration of antipsychotic drugs: correlation with leptin, insulin and reproductive hormones.
    Baptista T; Lacruz A; de Mendoza S; Mendoza Guillén JM; Silvera R; Angeles F; Mendoza MT; Hernández L
    Pharmacopsychiatry; 2000 May; 33(3):81-8. PubMed ID: 10855458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-related metabolic changes during treatment with valproate in patients with epilepsy.
    Pylvänen V; Pakarinen A; Knip M; Isojärvi J
    Epilepsy Behav; 2006 May; 8(3):643-8. PubMed ID: 16600693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sodium valproate versus lamotrigine: a randomised comparison of efficacy, tolerability and effects on circulating androgenic hormones in newly diagnosed epilepsy.
    Stephen LJ; Sills GJ; Leach JP; Butler E; Parker P; Hitiris N; Leach VM; Wilson EA; Brodie MJ
    Epilepsy Res; 2007 Jul; 75(2-3):122-9. PubMed ID: 17553671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valproic acid-associated weight gain in older children and teens with epilepsy.
    Wirrell EC
    Pediatr Neurol; 2003 Feb; 28(2):126-9. PubMed ID: 12699863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ghrelin levels are reduced in prepubertal epileptic children under treatment with carbamazepine or valproic acid.
    Prodam F; Bellone S; Casara G; De Rienzo F; Grassino EC; Bonsignori I; Demarchi I; Rapa A; Radetti G; Bona G
    Epilepsia; 2010 Feb; 51(2):312-5. PubMed ID: 19780793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age, insulin, SHBG and sex steroids exert secondary influence on plasma leptin level in women.
    Milewicz T; Krzysiek J; Janczak-Saif A; Sztefko K; Krzyczkowska-Sendrakowska M
    Endokrynol Pol; 2005; 56(6):883-90. PubMed ID: 16821206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical derangements related to metabolic syndrome in epileptic patients on treatment with valproic acid.
    Nisha Y; Bobby Z; Wadwekar V
    Seizure; 2018 Aug; 60():57-60. PubMed ID: 29906708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valproate-induced insulin resistance and obesity in children.
    Verrotti A; la Torre R; Trotta D; Mohn A; Chiarelli F
    Horm Res; 2009; 71(3):125-31. PubMed ID: 19188736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Weight gain associated with valproate in childhood.
    Demir E; Aysun S
    Pediatr Neurol; 2000 May; 22(5):361-4. PubMed ID: 10913727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity and plasma concentrations of alpha-tocopherol and beta-carotene in epileptic girls treated with valproate.
    Verrotti A; Greco R; Latini G; De Simone M; Chiarelli F
    Neuroendocrinology; 2004 Mar; 79(3):157-62. PubMed ID: 15103229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of valproate on serum leptin, insulin, and lipid levels in epileptic children.
    Kilic H; Demirel A; Uysal S
    Pediatr Int; 2021 Nov; 63(11):1351-1356. PubMed ID: 33657654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.